Beam Therapeutics Inc.

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Christine Bellon, SVP and CLO
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Beam Therapeutics Inc.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Verve Therapeutics, Inc. 10%+ Owner Common Stock 546,970 $5,469,700 $10.00 21 Jun 2021 Direct
Verve Therapeutics, Inc. 10%+ Owner Series A Convertible Preferred Stock 0 21 Jun 2021 Direct

Insider Reports Filed by Beam Therapeutics Inc.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VERV Verve Therapeutics, Inc. 21 Jun 2021 2 $0 4 10%+ Owner 23 Jun 2021, 16:30
VERV Verve Therapeutics, Inc. 16 Jun 2021 0 $0 3 10%+ Owner 16 Jun 2021, 21:11